Abstract
Purpose
In this systematic review and meta-analysis, we investigated the effect and side effects of Citrullus colocynthis on glycemic factors and lipid profile in diabetic patients.
Methods
We systematically searched English and Persian databases from inception till August 2021 using Medical Subject Headings (MeSH). Two authors independently extracted data and assessed the quality of studies. The standardized mean differences were pooled using fixed-effect models, and statistical heterogeneity was assessed using the I squared (I²) index.
Results
Of the 321 articles searched in the databases, 136 related articles were screened, 14 relevant full-text articles were assessed for eligibility; finally, four articles were included in the study, three articles were entered into the meta-analysis. The results of the meta-analysis indicated that Citrullus colocynthis does not have a significant effect on fasting blood sugar (FBS), hemoglobin A1c (HBA1c), low-density lipoprotein (LDL), total cholesterol, and triglyceride indices but increases high-density lipoprotein (HDL) (Mean Difference: 5.76; 95% CI: 1.69 to 9.84; P = 0.006; I2 = 0%).
Conclusions
The meta-analysis results showed that Citrullus colocynthis has no significant effect on glycemic and metabolic indices of diabetes - except HDL. Due to the relatively low quality and the small number of included trials, conducting further large scale well-designed randomized clinical trials to determine the effect of Citrullus colocynthis on glycemic and metabolic indices seems essential.
Similar content being viewed by others
References
Alam U, Asghar O, Azmi S, Malik RA. General aspects of diabetes mellitus. Handb Clin Neurol. 2014;126:211–22.
Kreider KE, Gabrielski AA, Hammonds FB. Hyperglycemia Syndromes. Nurs Clin North Am. 2018;53(3):303–17.
Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care. 2008;31(1):96–8.
Tan SY, Mei Wong JL, Sim YJ, Wong SS, Mohamed Elhassan SA, Tan SH, et al. Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention. Diabetes Metab Syndr. 2019;13(1):364–72.
Baker JR, O’Connor JP, Metcalf PA, Lawson MR, Johnson RN. Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus. Br Med J. 1983;287(6396):863–7.
Arneth B, Arneth R, Shams M. Metabolomics of Type 1 and Type 2 Diabetes. Int J Mol Sci. 2019;20(10):2467.
Feingold KR. Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes. 2021 Aug 28. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K, Grossman A, Hershman JM, Hofland J, Kalra S, Kaltsas G, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, McGee EA, McLachlan R, Morley JE, New M, Purnell J, Sahay R, Singer F, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
Barghamdi B, Ghorat F, Asadollahi K, Sayehmiri K, Peyghambari R, Abangah G. Therapeutic effects of Citrullus colocynthis fruit in patients with type II diabetes: A clinical trial study. J Pharm Bioallied Sci. 2016;8(2):130–4.
Moradi Y, Baradaran HR, Djalalinia S, Chinekesh A, Khamseh ME, Dastoorpoor M, et al. Complications of type 2 diabetes in Iranian population: An updated systematic review and meta-analysis. Diabetol Metab Syndr. 2019;13(3):2300–12.
Huseini HF, Darvishzadeh F, Heshmat R, Jafariazar Z, Raza M, Larijani B. The clinical investigation of Citrullus colocynthis (L.) schrad fruit in treatment of Type II diabetic patients: a randomized, double blind, placebo-controlled clinical trial. Phytother Res. 2009;23(8):1186–9.
Rahimi R, Amin G, Ardekani MR. A review on Citrullus colocynthis Schrad.: from traditional Iranian medicine to modern phytotherapy. J Altern Complement Med. 2012;18(6):551–4.
Gupta S, Koirala J, Khardori R, Khardori N. Infections in diabetes mellitus and hyperglycemia. Infect Dis Clin North Am. 2007;21(3):617–38.
Fallah Huseini H, Heshmat R, Larijani B, Fakhrzadeh H, Jafariazar Z, Darvishzadeh F, et al. The clinical investigation of Citrullus colocynthis (L.) Schrad. fruit in treatment of type II diabetic patients a randomized, double-blind, placebo-controlled study. J Med Plants. 2006;1(17):31–5.
Fallah Huseini H, Zaree A, Heshmat R, Larijani B, Fakhrzadeh H, Rezaii Sharifabadi R, et al. The effect of Citrullus colocynthis (L.) Schrad. fruit on oxidative stress parameters in type II diabetic patients. J Med Plants. 2006;1(17):55–60.
Hassan M, Niazi AT, Khan S, Gul F. Antidiabetic and antihyperlipidemic effects of artemisia absinthium l., citrullus colocynthis (l.) schrad. and gymnema sylvestre (retz.) r.br. ex sm. on type II diabetes hyperlipidemic patients. Indian J Tradit Knowl. 2018;17:233–9.
Li Y, Zheng M, Zhai X, Huang Y, Khalid A, Malik A, et al. Effect of-gymnema sylvestre, citrullus colocynthis and artemisia absinthium on blood glucose and lipid profile in diabetic human. Acta Pol Pharm. 2015;72(5):981–5.
Yaghoobi M, Miri-Moghaddam E, Navidian A, Nikbakht R, Mehrafarin A, Fallah Huseini H. Safety and Efficacy of processed Citrullus colocynthis L. Fruit in treatment of hyperlipidemic type II diabetic patients: a randomized, placebo-controlled clinical trial. J Med Plants. 2014;4(52):81–8.
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
Higgins JPGS. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011;343.
Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre; 2014.
Rahbar AR, Nabipour I. The hypolipidemic effect of Citrullus colocynthis on patients with hyperlipidemia. Pak J Biol Sci. 2010;13(24):1202–7.
Ahangarpour A, Belali R, Bineshfar F, Javadzadeh S, Yazdanpanah L. Evaluation of skin absorption of the Citrullus colocynthis in treatment of type II diabetic patients. J Diabetes Metab Disord. 2020;19(1):305–9.
Sanjari M. Evaluation of the efficacy of gel and aqueous extract of Citrullus colocynthis (L.) Schrad in patients with type 2 diabetes referring to Kerman diabetes clinic. 2018.
M. H. Alabnya an al-Haghayegh al-Advia [in Persian]. Tehran: Tehran University; 1992.
M. R. Alhavi fi-al-tib [in Arabic]. Beirut: Dar Al_Kotob Al-ilmiyah; 2000.
Tehran. Tohfeh al-Momenin [in Persian]. Iran: Shahid Beheshti University of Medical Sciences; 2007.
Sina I. Al Qanun Fi al-Tibb Persian translated by Sharafkandi A. Tehran: Soroush Press; 2005.
Daradka H, Almasad MM, Qazan W, El-Banna NM, Samara OH. Hypolipidaemic effects of Citrullus colocynthis L. in rabbits. Pak J Biol Sci. 2007;10(16):2768–71.
Dhanotia R, Chauhan NS, Saraf DK, Dixit VK. Effect of Citrullus colocynthis Schrad fruits on testosterone-induced alopecia. Nat Prod Res. 2011;25(15):1432–43.
Kumar S, Kumar D, Manjusha, Saroha K, Singh N, Vashishta B. Antioxidant and free radical scavenging potential of Citrullus colocynthis (L.) Schrad. methanolic fruit extract. Acta Pharm. 2008;58(2):215–20.
Marzouk B, Marzouk Z, Décor R, Edziri H, Haloui E, Fenina N, et al. Antibacterial and anticandidal screening of Tunisian Citrullus colocynthis Schrad. from Medenine. J Ethnopharmacol. 2009;125(2):344–9.
MH. A. Makhzan-al-Advia [in Persian]. Tehran: Tehran University of Medical Sciences; 2009.
Bharti SK, Krishnan S, Kumar A, Kumar A. Antidiabetic phytoconstituents and their mode of action on metabolic pathways. Ther Adv Endocrinol Metab. 2018;9(3):81–100.
Karimabad MN, Niknia S, Golnabadi MB, Poor SF, Hajizadeh MR, Mahmoodi M. Effect of Citrullus colocynthis Extract on Glycated Hemoglobin Formation (In Vitro). Eurasian J Med. 2020;52(1):47–51.
Benariba N, Djaziri R, Bellakhdar W, Belkacem N, Kadiata M, Malaisse WJ, et al. Phytochemical screening and free radical scavenging activity of Citrullus colocynthis seeds extracts. Asian Pac J Trop Biomed. 2013;3(1):35–40.
Javadzadeh HR, Davoudi A, Davoudi F, Valizadegan G, Goodarzi H, Mahmoodi S, et al. Citrullus colocynthis as the Cause of Acute Rectorrhagia. Case Rep Emerg Med. 2013;2013:652192.
Savaj S, Ghaffari M, Abbasi MA, Azar J. Acute interstitial nephritis induced by Citrullus Colocynthis. Iran J Kidney Dis. 2017;11(5):385–7.
Qazan W, Almasad MM, Daradka H. Short and long effects of Citrullus colocynthis L. on reproductive system and fertility in female Spague-Dawley rats. Pak J Biol Sci. 2007;10(16):2699–703.
Al-Yahya MA, AH AL-F, Adam SE. Preliminary toxicity study on the individual and combined effects of Citrullus colocynthis and Nerium oleander in rats. Fitoterapia. 2000;71(4):385–91.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 31 KB)
Rights and permissions
About this article
Cite this article
Jafarizadeh, A., Raeisi, S.A., Ghassab-Abdollahi, N. et al. Effect of Citrullus colocynthis on glycemic factors and lipid profile in type II diabetic patients: a systematic review and meta-analysis. J Diabetes Metab Disord 21, 1785–1795 (2022). https://doi.org/10.1007/s40200-022-01045-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40200-022-01045-9